FindTrial
Sign In

Calcipotriene

DRUG10 trials

Sponsors

LEO Pharma, Eisai Limited, University of California, Los Angeles, Leon Kircik, M.D., Medical College of Wisconsin

Conditions

Acne VulgarisActinic KeratosisAtopic DermatitisCarcinoma, Squamous CellGraft Vs Host DiseasePruritusPsoriasisPsoriasis Vulgaris

Phase 1

Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea
WithdrawnNCT02680717
Medical College of WisconsinScleroderma
Start: 2016-03-31End: 2017-05-31Updated: 2018-07-18
Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC
RecruitingNCT03370406
Melissa Pugliano-MauroCarcinoma, Squamous Cell
Start: 2018-08-03End: 2026-10-30Target: 30Updated: 2025-06-15

Phase 2

A 12-Day Randomized, Blinded, Vehicle and Active Comparator-Controlled Study to Determine the Efficacy and Safety of Six Concentrations of Topical E6201 Gel in Subjects With Psoriasis Vulgaris
CompletedNCT01268527
Eisai LimitedPsoriasis Vulgaris
Start: 2010-03-15End: 2010-12-11Updated: 2021-06-11
Clinical Trial to Determine the Efficacy of Vitamin D for Acne Therapy
CompletedNCT01694433
University of California, Los AngelesAcne Vulgaris
Start: 2013-02-28End: 2014-01-09Updated: 2019-05-07
Safety, Tolerability and Efficacy of SNA-120 for Treatment of Pruritus and Psoriasis in Subjects Treated With Calcipotriene
CompletedNCT03448081
Sienna BiopharmaceuticalsPruritus, Psoriasis
Start: 2018-02-12End: 2018-12-10Updated: 2019-02-08
Testing the Efficacy of Topical Calcipotriene Plus 5-Fluorouracil Combination to Activate the Immune System Against Precancerous Skin Lesions in Organ Transplant Recipients
Active, not recruitingNCT05699603
University of ArizonaActinic Keratosis
Start: 2024-07-02End: 2029-02-01Target: 56Updated: 2025-09-24

Phase 3

LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs)
CompletedNCT01188928
LEO PharmaPsoriasis Vulgaris
Start: 2010-09-30End: 2011-03-31Updated: 2025-03-10

Phase 4

Olux E Foam and Sorilux Foam Combination Therapy for the Maintenance of Treatment Response in Patients With Moderate Plaque Psoriasis
CompletedNCT01745133
Leon Kircik, M.D.Psoriasis
Start: 2013-01-31End: 2014-08-31Updated: 2016-11-17
Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
Not yet recruitingNCT07352566
University of California, San FranciscoAtopic Dermatitis, Psoriasis
Start: 2026-01-01End: 2030-06-01Target: 10Updated: 2026-01-20

Unknown Phase

Topical Vitamin D in Acute Graft Versus Host Disease of the Skin
CompletedNCT03093805
Children's Hospital Medical Center, CincinnatiGraft Vs Host Disease
Start: 2017-03-15End: 2019-03-26Updated: 2019-06-12